BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1949716)

  • 1. Complement is not activated in AB0-haemolytic disease of the newborn: two exceptions.
    Pujol M; Ribera A; Abella E; Natal A; Bel J; Coroleu W
    Vox Sang; 1991; 61(1):76. PubMed ID: 1949716
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement is not activated in AB0-hemolytic disease of the newborn: further support.
    Carreras Vescio LA; Castro RA
    Vox Sang; 1990; 58(3):231. PubMed ID: 2339535
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement is not activated in ABO-haemolytic disease of the newborn.
    Brouwers HA; Overbeeke MA; Huiskes E; Bos MJ; Ouwehand WH; Engelfriet CP
    Br J Haematol; 1988 Mar; 68(3):363-6. PubMed ID: 3258530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetomaternal AB0 incompatibility and erythroblastosis fetalis.
    Bowman JM
    Vox Sang; 1986; 50(2):104-6. PubMed ID: 3083588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO haemolytic disease of the newborn: laboratory prediction and post-natal diagnosis.
    Lockyer WJ
    Med Lab Sci; 1982 Jul; 39(3):287-95. PubMed ID: 6752621
    [No Abstract]   [Full Text] [Related]  

  • 6. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elution technics for the detection of antibodies in hemolytic disease of the newborn].
    Gota F; Dallavalle FM
    Arch Sci Med (Torino); 1980; 137(4):567-9. PubMed ID: 7018457
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems of ABO hemolytic disease in the newborn infant].
    Novachev D; Markov L
    Akush Ginekol (Sofiia); 1980; 19(3):253-7. PubMed ID: 6992621
    [No Abstract]   [Full Text] [Related]  

  • 9. [ABO immunological afectation of newborns, between heterospecific ABO pregnancy and haemolytic ABO disease. A study of 156 cases (author's transl)].
    Calabuig MT; Sanchez-Fayos J; Outeiriño J; Serrano J; Pérez Iglesias F; Pérez Piño T; Paniagua G
    Sangre (Barc); 1977; 22(4):409-20. PubMed ID: 897951
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A mother.
    Wang M; Hays T; Ambruso DR; Silliman CC; Dickey WC
    Pediatr Blood Cancer; 2005 Nov; 45(6):861-2. PubMed ID: 16007582
    [No Abstract]   [Full Text] [Related]  

  • 11. The pathogenesis of ABO haemolytic disease of the newborn.
    Voak D
    Vox Sang; 1969 Dec; 17(6):481-513. PubMed ID: 5373123
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum blood group substances and ABO haemolytic disease.
    Denborough MA; Downing HJ; Doig AG
    Br J Haematol; 1969; 16(1):103-9. PubMed ID: 5795201
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aspects of ABO blood group incompatibility in the pre- and postnatal periods].
    Novachev D; Markov L
    Akush Ginekol (Sofiia); 1980; 19(4):322-8. PubMed ID: 6774626
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement in ABO--hemolytic disease of the newborn.
    Wang MY; Desforges JF
    Pediatrics; 1971 Oct; 48(4):650-3. PubMed ID: 5165506
    [No Abstract]   [Full Text] [Related]  

  • 15. ABO hemolytic disease, complement, and phagocytosis.
    Gordon BD; Desforges J
    Pediatrics; 1972 Jul; 50(1):169. PubMed ID: 5038101
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of the Coombs test in ABO incompatibility].
    Bel Comos J; Ribera Crusafont A; Natal Pujol A; Coroleu Lletget W; Pujol Posch N; Prats Viñas J
    An Esp Pediatr; 1991 Oct; 35(4):248-50. PubMed ID: 1763851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemolytic disease of the newborn due to ABO incompatibility. A new aid to diagnosis.
    Moores P; Grobbelaar BG; Ward V
    Acta Haematol; 1970; 44(1):47-51. PubMed ID: 4991327
    [No Abstract]   [Full Text] [Related]  

  • 18. What is the best predictor of the severity of ABO-haemolytic disease of the newborn?
    Brouwers HA; Overbeeke MA; van Ertbruggen I; Schaasberg W; Alsbach GP; van der Heiden C; van Leeuwen EF; Stoop JW; Engelfriet CP
    Lancet; 1988 Sep; 2(8612):641-4. PubMed ID: 2901516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected serological results in haemolytic disease of the newborn.
    Lowes BC
    J Med Lab Technol; 1970 Oct; 27(4):475-7. PubMed ID: 4992539
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum complement in hemolytic disease of the newborn].
    Gravina E; Gravina-Sanvitale G
    Minerva Pediatr; 1971 Feb; 23(5):199-203. PubMed ID: 4995757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.